TLK-286. Academic Article Review

•  
• Overview
•  
• Research
•  
• Identity
•  
• Additional Document Info
•  
• View All
•  

Overview

abstract

• Telik Inc is developing TLK-286, a modified glutathione analog prodrug, for the potential treatment of cancer.

authors

• Cathcart, Cynthia
• Lee, Fa Chyi
• Norenberg, Jeffrey
• Smith, Harriet O
• Verschraegen, Claire F

publication date

• August 2004

published in

• IDrugs : the investigational drugs journal  Journal

Research

keywords

• Animals
• Antineoplastic Agents
• Clinical Trials as Topic
• Drugs, Investigational
• Glutathione
• Humans
• Neoplasms

Identity

PubMed ID

• 15334311

Additional Document Info

start page

• 771

end page

• 781

volume

• 7

number

• 8